European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
BACKGROUND AND OBJECTIVE: We present a summary of part II of the 2024 update of the European Association of Urology (EAU)/European Society of Paediatric Urology (ESPU) guidelines on paediatric urology. The summary provides evidence-based standards for management of a number of urological conditions in the paediatric population. The aim is to provide practical recommendations for clinical management of these conditions with a focus on diagnosis, treatment, and follow-up. METHODS: For the guidelines update, new and relevant evidence was identified, collated, and appraised via a structured assessment of the literature. Databases searched included Medline, EMBASE, and the Cochrane Libraries. Recommendations in the guidelines were developed by the panel to prioritise clinically important care decisions. The strength of each recommendation was determined according to a balance between desirable and undesirable consequences of alternative management strategies, the quality of the evidence (including the certainty of estimates), and the nature and variability of patient values and preferences. KEY FINDINGS AND LIMITATIONS: Key recommendations emphasise the importance of thorough diagnosis, treatment, and follow-up for patients with the conditions outlines. The guidelines stress the importance of a multidisciplinary approach to treatment and the importance of shared decision-making with patients and their guardians/caregivers. The summary provides evidence-based standards for management of undescended testes, testicular tumours in prepubertal boys, acute scrotum, hypospadias, congenital penile curvature, urinary tract infections, daytime lower urinary tract conditions, urachal remnants, and transitional urology. CONCLUSIONS AND CLINICAL IMPLICATIONS: Part II of the 2024 EAU/ESPU guidelines provides updated guidance for evidence-based management of a number of paediatric urological conditions, with recommendations designed for effective integration into clinical practice.